Progestogen effects on coronary arteries: the need for definitive clinical trials

被引：4

作者：

Archer, DF ^{[1
]}

机构：

[1] Eastern Virginia Med Sch, Norfolk, VA 23501 USA

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2001年 / 8卷 / 01期

关键词：

D O I：

10.1097/00042192-200101000-00001

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：1 / 2

页数：2

共 19 条

[1] Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis [J].

Adams, MR ;

Golden, DL ;

Wagner, JD ;

Williams, JK .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :217-221

[2] Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene [J].

Barrett-Connor, E ;

Wenger, NK ;

Grady, D ;

Mosca, L ;

Collins, P ;

Kornitzer, M ;

Cox, DA ;

Moscarelli, E ;

Anderson, PW .

JOURNAL OF WOMENS HEALTH, 1998, 7 (07) :839-847

[3] The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women [J].

BarrettConnor, E ;

Slone, S ;

Greendale, G ;

KritzSilverstein, D ;

Espeland, M ;

Johnson, SR ;

Waclawiw, M ;

Fineberg, SE .

MATURITAS, 1997, 27 (03) :261-274

[4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[5] Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease [J].

Ferrari, R ;

Ceconi, C ;

Curello, S ;

Pepi, P ;

Mazzoletti, A ;

Visioli, O .

CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 :639-647

[6] HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CANCER RISK - A METAANALYSIS [J].

GRADY, D ;

GEBRETSADIK, T ;

KERLIKOWSKE, K ;

ERNSTER, V ;

PETITTI, D .

OBSTETRICS AND GYNECOLOGY, 1995, 85 (02) :304-313

[7] THE EPIDEMIOLOGY OF CORONARY HEART-DISEASE AND ESTROGEN REPLACEMENT IN POSTMENOPAUSAL WOMEN [J].

GRODSTEIN, F ;

STAMPFER, M .

PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (03) :199-210

[8] Effect of 17-β estradiol on pre-existing atherosclerotic lesions:: role of the endothelium [J].

Hanke, H ;

Kamenz, J ;

Hanke, S ;

Spiess, J ;

Lenz, C ;

Brehme, U ;

Bruck, B ;

Finking, G ;

Hombach, V .

ATHEROSCLEROSIS, 1999, 147 (01) :123-132

[9] Effects of estrogen replacement on the progression of coronary-artery atherosclerosis [J].

Herrington, DM ;

Reboussin, DM ;

Brosnihan, KB ;

Sharp, PC ;

Shumaker, SA ;

Snyder, TE ;

Furberg, CD ;

Kowalchuk, GJ ;

Stuckey, TD ;

Rogers, WJ ;

Givens, DH ;

Waters, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08) :522-529

[10] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].

Hulley, S ;

Grady, D ;

Bush, T ;

Furberg, C ;

Herrington, D ;

Riggs, B ;

Vittinghoff, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613

← 1 2 →